Some medicines exempted from customs duty are asciminib, mepolizumab, daratumumab, daratumumab subcutaneous, teclistamab, amivantamab, alectinib, risdiplam and obinutuzumab. Entrectinib, spesolimab, idursulphatase, laronidase, tepotinib, miglustat, alirocumab, evolocumab, inclisiran, velmanase alfa have also been exempted. The list also includes imiglucerase and cystamine bitartrate.